Tus Pharmaceutical Group Co Ltd (000590.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE000000701
Tus Pharmaceutical Group Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 343.21 m CNY | 337.67 m CNY |
| Gross profit | 159.87 m CNY | 151.11 m CNY |
| Operating income | -168.68 m CNY | -18.76 m CNY |
| EBIT | -118.39 m CNY | -46.20 m CNY |
| Net income | -125.47 m CNY | -50.52 m CNY |
| Diluted EPS – continuing operations | -0.52 CNY | -0.21 CNY |
Full history since 1992, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Tus Pharmaceutical Group Co Ltd
Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food under the Guhan brand in China. It operates through the Pharmaceutical and Health Product Manufacturing and Sales Business, Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business, and Other Business segments. The company offers prescription and over-the-counter drugs, such as tonics, cardiovascular drugs, children's nutritional supplements, cold and flu remedies, and heat-clearing and detoxifying drugs. It also engages in nutrition and health consulting services; Chinese herbal medicine cultivation; medical research and experimental development; cultural and artistic exchange planning; medical consultation; internet sales; technology promotion, consulting, and agency services; outpatient services; and pharmaceutical wholesale and retail activities. The company was formerly known as Tus-Pharmaceutical Group Co., Ltd. and changed its name to Guhan Pharmaceutical Group Co., Ltd. in November 2025. Guhan Pharmaceutical Group Co., Ltd. was founded in 1956 and is headquartered in Hengyang, China.
More stocks
- Thaicom Public Company Limited (THCOM.BK)
- Profound Medical Corp. (PROF)
- HAWTHORN BANCSHARES, INC. (HWBK)
- Oak Valley Bancorp (OVLY)
- StealthGas Inc (GASS)
- Orchestra BioMed Holdings, Inc. (OBIO)
- VEEA INC. (VEEA)
- Bit Digital, Inc (BTBT)
- Eche Izquierdo (EISA.SN)
- Mediclin (MED.DE)
- Ningbo Yibin Electronic Technology Co. Ltd. Cl A (001278.SZ)
- Novetum (5NB.DU)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.